FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donald Cutlip

Research Profile

Devices

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Neil J Wimmer; Robert W Yeh; Donald E Cutlip; Laura Mauri
Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients.
Donald E Cutlip; Duane S Pinto
Extracranial carotid disease revascularization.
Michael W Donnino; Sarah Farris; Shiva Gautam; Matthew Bivens; Michael N Cocchi; Donald E Cutlip; Joseph C Miller; Justin D Salciccioli; Michael Howell
A pilot study examining the severity and outcome of the post-cardiac arrest syndrome: a comparative analysis of two geographically distinct hospitals.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donald Cutlip (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Neil J Wimmer; Robert W Yeh; Donald E Cutlip; Laura Mauri
Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients.
Stroke; a journal of cerebral circulation 2012;43(12):3218-24.
2012: Donald E Cutlip; Duane S Pinto
Extracranial carotid disease revascularization.
Circulation 2012;126(22):2636-44.
2012: Michael W Donnino; Sarah Farris; Shiva Gautam; Matthew Bivens; Michael N Cocchi; Donald E Cutlip; Joseph C Miller; Justin D Salciccioli; Michael Howell
A pilot study examining the severity and outcome of the post-cardiac arrest syndrome: a comparative analysis of two geographically distinct hospitals.
Circulation 2012;126(12):1478-83.
2012: Shalin J Patel; Elliot B Tapper; Donald E Cutlip
Clinical pearls regarding Prinzmetal's angina complicated by cardiac arrest - management during therapeutic hypothermia.
International journal of cardiology 2012;159(1):55-7.
2012: Lisa M Fleming; Manuela Negoita; Lena Novack; Victor Novack; Sidney A Cohen; Donald E Cutlip
Frequency and impact of bleeding in elective coronary stent clinical trials--utility of three commonly used definitions.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;80(2):E23-9.
2012: William A Gray; Timothy D Henry; James Hermiller; Hubertus Heuer; J Tift Mann; Mark G Midei; Charles O'Shaughnessy; Paul A Overlie; Jeffrey J Popma; Louis A Cannon; Jessie Coe; Donald E Cutlip; Peter J Fitzgerald; Thomas D Stuckey; Robert Whitbourn; David O Williams; Alan C Yeung; Lewis B Schwartz
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
International journal of cardiology 2012;157(1):96-101.
2012: M Hassan Pervaiz; Poornima Sood; Gregg W Stone; Xiaolu Su; Krishnankutty Sudhir; John Wang; Manejeh Yaqub; Kyoko Hattori; James B Hermiller; Liming Hou; Dean J Kereiakes; Robert J Applegate; Sherry Cao; Donald E Cutlip
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.
Circulation. Cardiovascular interventions 2012;5(2):150-6.
2011: Alan C Yeung; Martin B Leon; Ash Jain; Thaddeus R Tolleson; Douglas J Spriggs; Brent T Mc Laurin; Jeffrey J Popma; Peter J Fitzgerald; Donald E Cutlip; Joseph M Massaro; Laura Mauri
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial.
Journal of the American College of Cardiology 2011;57(17):1778-83.
2011: Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-angèle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick Washington Serruys
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
Journal of the American College of Cardiology 2011;57(3):253-69.
2011: Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-angèle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick Washington Serruys
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
European heart journal 2011;32(2):205-17.
2010: Laura Mauri; Joseph M Massaro; Songtao Jiang; Ian Meredith; William Wijns; Jean Fajadet; David E Kandzari; Martin B Leon; Donald E Cutlip; Kweli P Thompson
Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents.
JACC. Cardiovascular interventions 2010;3(12):1240-9.
2010: Victor Novack; Lisa Battaglia; Jeffrey J Popma; Donald E Cutlip
In-hospital and nine-month outcomes among patients with coronary lesions involving a side branch and treated with bare metal stents.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;76(7):951-7.
2010: Pallav Garg; David M Charytan; Lena Novack; Donald E Cutlip; Jeffrey J Popma; Jeffrey Moses; Martin B Leon; Joachim Schofer; Guenter Breithardt; Erick Schampaert; Laura Mauri
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials).
The American journal of cardiology 2010;106(10):1436-42.
2010: Martin B Leon; Eugenia Nikolsky; Donald E Cutlip; Laura Mauri; Henry Liberman; Hadley Wilson; John Patterson; Jeffrey Moses; David E Kandzari
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
JACC. Cardiovascular interventions 2010;3(10):1043-50.
2010: Victor Novack; Michael C Nguyen; Meredith Rooney; Riya Chacko; Lena Novack; Michael Pencina; Patricia Apruzzese; Laura Mauri; Sidney A Cohen; Jeffrey Moses; Martin B Leon; Donald E Cutlip
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents.
The American journal of cardiology 2010;106(6):774-9.
2010: Martin B Leon; Laura Mauri; Jeffrey J Popma; Donald E Cutlip; Eugenia Nikolsky; Charles O'Shaughnessy; Paul A Overlie; Brent T McLaurin; Stuart L Solomon; John S Douglas; Michael W Ball; Ronald P Caputo; Ash Jain; Thaddeus R Tolleson; Bernard M Reen; Ajay J Kirtane; Peter J Fitzgerald; Kweli Thompson; David E Kandzari
A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.
Journal of the American College of Cardiology 2010;55(6):543-54.
2009: Martin B Leon; David E Kandzari; Eric L Eisenstein; Kevin J Anstrom; Laura Mauri; Donald E Cutlip; Eugenia Nikolsky; Charles O'Shaughnessy; Paul A Overlie; Ajay J Kirtane; Brent T McLaurin; Stuart L Solomon; John S Douglas; Jeffrey J Popma
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
JACC. Cardiovascular interventions 2009;2(12):1208-18.
2009: Eugenia Nikolsky; Alexandra J Lansky; Krishnankutty Sudhir; Julie Doostzadeh; Donald E Cutlip; Robert Piana; Xiaolu Su; Roseann White; Charles A Simonton; Gregg W Stone
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
American heart journal 2009;158(4):520-526.e2.
2009: Victor Novack; Donald E Cutlip; Neal Kleiman; Michael Pencina; Laura Mauri; Chen-Hsing Yen; Peter Berger; Steven Goldberg; Mirle Kellett; Ronald Waksman; Mun Hong; Albert E Raizner; David J Cohen
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
JACC. Cardiovascular interventions 2009;2(8):767-75.
2009: Victor Novack; Daniel Tsyvine; David J Cohen; Michael Pencina; Joseph Dubin; Hossein Dehghani; Neal S Kleiman; Donald E Cutlip
Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(7):874-80.
2008: Pascal Vranckx; Peter-Paul Kint; Marie-angèle Morel; Gerrit-Anne van Es; Patrick Washington Serruys; Donald E Cutlip
Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008;4 Suppl C():C39-44.
2008: Gregg W Stone; Mark Midei; William Newman; Mark Sanz; James B Hermiller; Jerome Williams; Naim Farhat; Kenneth W Mahaffey; Donald E Cutlip; Peter J Fitzgerald; Poornima Sood; Xiaolu Su; Alexandra J Lansky
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
JAMA : the journal of the American Medical Association 2008;299(16):1903-13.
2008: Michael J Rinaldi; Ajay J Kirtane; Robert N Piana; Ronald P Caputo; Paul C Gordon; JJ Lopez; Harold L Dauerman; Thomas Ryan; Francis J Kiernan; Donald E Cutlip; Kalon K L Ho; C Michael Gibson; Sabina A Murphy; David J Cohen
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
American heart journal 2008;155(4):654-60.
2008: Alanna Coolong; Donald S Baim; Richard E Kuntz; A James O'Malley; Sachin Marulkar; Donald E Cutlip; Jeffrey J Popma; Laura Mauri
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.
Circulation 2008;117(6):790-7.
2007: Jason Ryan; Donald E Cutlip; David J Cohen; Duane S Pinto
Drug eluting stents for ST-elevation myocardial infarction: risk and benefit.
Journal of thrombosis and thrombolysis 2007;24(3):293-9.
2007: Emilia Solinas; Eugenia Nikolsky; Alexandra J Lansky; Ajay J Kirtane; Marie-Claude Morice; Jeffrey J Popma; Joachim Schofer; Erick Schampaert; Tereza Pucelikova; Jiro Aoki; Martin Fahy; George Dangas; Jeffrey W Moses; Donald E Cutlip; Martin B Leon; Roxana Mehran
Gender-specific outcomes after sirolimus-eluting stent implantation.
Journal of the American College of Cardiology 2007;50(22):2111-6.
2007: Ramon Kumar; Tobias T Lee; Allen Jeremias; Christopher P Ruisi; Brett Sylvia; Jorge Magallon; Ajay J Kirtane; Brian Bigelow; Martin Abrahamson; Duane S Pinto; Kalon K L Ho; David J Cohen; Joseph P Carrozza; Donald E Cutlip
Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
The American journal of cardiology 2007;100(8):1187-91.
2007: Marie-Claude Morice; Patrick Washington Serruys; Paul Barragan; Christoph Bode; Gerrit-Anne van Es; Hans-Peter Stoll; David Snead; Laura Mauri; Donald E Cutlip; Eduardo Sousa
Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
Journal of the American College of Cardiology 2007;50(14):1299-304.
2007: David M Charytan; John P Forman; Donald E Cutlip
Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(9):2578-85.
2007: Gregg W Stone; Stephen G Ellis; Antonio Colombo; Keith D Dawkins; Eberhard Grube; Donald E Cutlip; Mark Friedman; Donald S Baim; Joerg Koglin
Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.
Circulation 2007;115(22):2842-7.
2007: Donald E Cutlip; Stephan Windecker; Roxana Mehran; Ashley Boam; David J Cohen; Gerrit-Anne van Es; Philippe Gabriel STEG; Marie-angèle Morel; Laura Mauri; Pascal Vranckx; Eugene McFadden; Alexandra Lansky; Martial Hamon; Mitchell W Krucoff; Patrick Washington Serruys
Clinical end points in coronary stent trials: a case for standardized definitions.
Circulation 2007;115(17):2344-51.
2007: Gregg W Stone; Jeffrey W Moses; Stephen G Ellis; Joachim Schofer; Keith D Dawkins; Marie-Claude Morice; Antonio Colombo; Erick Schampaert; Eberhard Grube; Ajay J Kirtane; Donald E Cutlip; Martin Fahy; Stuart J Pocock; Roxana Mehran; Martin B Leon
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
The New England journal of medicine 2007;356(10):998-1008.
2007: Laura Mauri; Wen-hua Hsieh; Joseph M Massaro; Kalon K L Ho; Ralph D'Agostino; Donald E Cutlip
Stent thrombosis in randomized clinical trials of drug-eluting stents.
The New England journal of medicine 2007;356(10):1020-9.
2006: Donald E Cutlip
Drug-eluting stent era: will we improve 5-year outcomes?
Coronary artery disease 2006;17(8):681-4.
2006: Duane S Pinto; Ajay J Kirtane; Brahmajee K Nallamothu; Sabina A Murphy; David J Cohen; Roger J Laham; Donald E Cutlip; Eric R Bates; Paul D Frederick; Dave P Miller; Joseph P Carrozza; Elliott M Antman; Christopher P Cannon; C Michael Gibson
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.
Circulation 2006;114(19):2019-25.
2006: Tobias T Lee; Loryn Feinberg; Donald S Baim; David R Holmes; Julian M Aroesty; Joseph P Carrozza; David J Cohen; Kalon K L Ho; Donald E Cutlip
Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials).
The American journal of cardiology 2006;98(6):718-21.
2006: Duane S Pinto; Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; J Tift Mann; Roxana Mehran; Yingbo Na; Mark Turco; Ronald Caputo; Jeffrey J Popma; Donald E Cutlip; Mary E Russell; David J Cohen
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
Journal of the American College of Cardiology 2006;48(1):32-6.
2006: Donald E Cutlip
Drug-eluting stent era: will we improve 5-year outcomes?
Coronary artery disease 2006;17(3):289-92.
2006: Giora Weisz; Martin B Leon; David R Holmes; Dean J Kereiakes; Mel R Clark; Barry M Cohen; Stephen G Ellis; Patrick Coleman; Carolyn Hill; Chunxue Shi; Donald E Cutlip; Richard E Kuntz; Jeffrey W Moses
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
Journal of the American College of Cardiology 2006;47(7):1350-5.
2005: Laura Mauri; E John Orav; Susana C Candia; Donald E Cutlip; Richard E Kuntz
Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
Circulation 2005;112(18):2833-9.
2005: Jamal S Rana; Murray A Mittleman; Kalon K L Ho; Donald E Cutlip
Obesity and clinical restenosis after coronary stent placement.
American heart journal 2005;150(4):821-6.
2005: Donald E Cutlip; Richard E Kuntz
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.
Circulation 2005;112(6):916-22; discussion 922.
2005: Laura Mauri; A James O'Malley; Jeffrey J Popma; Jeffrey W Moses; Martin B Leon; David R Holmes; Paul S Teirstein; Donald E Cutlip; Dennis Donahoe; Richard E Kuntz
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
The American journal of cardiology 2005;95(10):1140-5.
2005: Laura Mauri; E John Orav; A James O'Malley; Jeffrey W Moses; Martin B Leon; David R Holmes; Paul S Teirstein; Joachim Schofer; Günter Breithardt; Donald E Cutlip; Dean J Kereiakes; Chunxue Shi; Brian G Firth; Dennis J Donohoe; Richard E Kuntz
Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.
Circulation 2005;111(3):321-7.
2005: Gregory R Giugliano; Richard E Kuntz; Jeffrey J Popma; Donald E Cutlip; Donald S Baim
Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device.
The American journal of cardiology 2005;95(2):173-7.
2005: Manish S Chauhan; Kalon K L Ho; Donald S Baim; Richard E Kuntz; Donald E Cutlip
Effect of gender on in-hospital and one-year outcomes after contemporary coronary artery stenting.
The American journal of cardiology 2005;95(1):101-4.
2004: David J Cohen; Sabina A Murphy; Donald S Baim; Tara A Lavelle; Ronna H Berezin; Donald E Cutlip; Kalon K L Ho; Richard E Kuntz
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
Journal of the American College of Cardiology 2004;44(9):1801-8.
2004: Jay S Yadav; Mark H Wholey; Richard E Kuntz; Pierre Fayad; Barry T Katzen; Gregory J Mishkel; Tanvir Bajwa; Patrick L Whitlow; Neil E Strickman; Michael R Jaff; Jeffrey J Popma; David B Snead; Donald E Cutlip; Brian G Firth; Kenneth Ouriel
Protected carotid-artery stenting versus endarterectomy in high-risk patients.
The New England journal of medicine 2004;351(15):1493-501.
2004: Donald S Baim; Greg Braden; Richard R Heuser; Jeffrey J Popma; Donald E Cutlip; Joseph M Massaro; Sachin Marulkar; Linda Arvay; Richard E Kuntz
Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study).
The American journal of cardiology 2004;94(7):853-8.
2004: Allen Jeremias; Donald S Baim; Kalon K L Ho; Manish Chauhan; Joseph P Carrozza; David J Cohen; Jeffrey J Popma; Richard E Kuntz; Donald E Cutlip
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
Journal of the American College of Cardiology 2004;44(6):1210-4.
2004: Donald E Cutlip; Amit G Chhabra; Donald S Baim; Manish S Chauhan; Sachin Marulkar; Joseph M Massaro; Ameet Bakhai; David J Cohen; Richard E Kuntz; Kalon K L Ho
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.
Circulation 2004;110(10):1226-30.
2004: Laura Mauri; A James O'Malley; Donald E Cutlip; Kalon K L Ho; Jeffrey J Popma; Manish S Chauhan; Donald S Baim; David J Cohen; Richard E Kuntz
Effects of stent length and lesion length on coronary restenosis.
The American journal of cardiology 2004;93(11):1340-6, A5.
2004: John McB Hodgson; Randy K Bottner; Lloyd W Klein; Howard T Walpole; David J Cohen; Donald E Cutlip; Randolph B Fenninger; Brian G Firth; Dan Greenberg; Ilona Kalisky; Thomas Meskan; Wayne Powell; Gregg W Stone; James P Zito; Mary Ann Clark
Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2004;62(1):1-17.
2004: Allen Jeremias; Brett Sylvia; Jonathan Bridges; Ajay J Kirtane; Brian Bigelow; Duane S Pinto; Kalon K L Ho; David J Cohen; Lawrence A Garcia; Donald E Cutlip; Joseph P Carrozza
Stent thrombosis after successful sirolimus-eluting stent implantation.
Circulation 2004;109(16):1930-2.
2004: David R Holmes; Martin B Leon; Jeffrey W Moses; Jeffrey J Popma; Donald E Cutlip; Peter J Fitzgerald; Charles Brown; Tim A Fischell; S Chiu Wong; Mark G Midei; David Snead; Richard E Kuntz
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
Circulation 2004;109(5):634-40.
2003: Donald E Cutlip; Mark J Ricciardi; Frederick S Ling; Joseph P Carrozza; Vineet Dua; Jason Garringer; Satyendra Giri; Ronald P Caputo
Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction.
The American journal of cardiology 2003;92(8):977-80.
2003: Laura Mauri; Mark Reisman; Maurice Buchbinder; Jeffrey J Popma; Samin K Sharma; Donald E Cutlip; Kalon K L Ho; Ross Prpic; Peter Zimetbaum; Richard E Kuntz
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART).
American heart journal 2003;145(5):847-54.
2002: Donald E Cutlip; Manish S Chauhan; Donald S Baim; Kalon K L Ho; Jeffrey J Popma; Joseph P Carrozza; David J Cohen; Richard E Kuntz
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
Journal of the American College of Cardiology 2002;40(12):2082-9.
2002: Laura Mauri; Raoul Bonan; Bonnie H Weiner; Victor Legrand; Jean-Pierre Bassand; Jeffrey J Popma; Paulette Niemyski; Ross Prpic; Kalon K L Ho; Manish S Chauhan; Donald E Cutlip; Olivier Bertrand; Richard E Kuntz
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial.
The American journal of cardiology 2002;90(10):1079-83.
2002: Donald S Baim; Dennis W Wahr; Barry George; Martin B Leon; Joel Greenberg; Donald E Cutlip; Unsal Kaya; Jeffrey J Popma; Kalon K L Ho; Richard E Kuntz
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
Circulation 2002;105(11):1285-90.
2001: Vijay G Kalaria; I Chaudhary; S Jacobson; R M Pomerantz; C J Cove; Frederick S Ling; Donald E Cutlip
Evolution in the practice of primary angioplasty: effect of adjunctive coronary stenting and glycoprotein IIb/IIIa inhibitors on long-term outcomes.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2001;54(3):327-32.
2001: David J Cohen; Stephen R Ramee; Donald S Baim; S Sharma; Joseph P Carrozza; Roberta S Cosgrove; N Jones; Ronna H Berezin; Donald E Cutlip; Kalon K L Ho; Richard E Kuntz
Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial.
American heart journal 2001;142(4):648-56.
2001: David J Cohen; M Doucet; Donald E Cutlip; Kalon K L Ho; Jeffrey J Popma; Richard E Kuntz
Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?
Circulation 2001;104(7):773-8.
2001: Donald E Cutlip; C J Cove; D Irons; Vijay G Kalaria; M Le; H Cronmiller; Lori Caufield; R M Pomerantz; Frederick S Ling
Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes.
The American journal of cardiology 2001;88(1):A6, 62-4.
2001: Donald E Cutlip; D S Baim; K K Ho; J J Popma; A J Lansky; D J Cohen; Joseph P Carrozza; M S Chauhan; O Rodriguez; R E Kuntz
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.
Circulation 2001;103(15):1967-71.
2001: Patrick L Whitlow; T A Bass; R M Kipperman; B L Sharaf; Kalon K L Ho; Donald E Cutlip; Y Zhang; Richard E Kuntz; David O Williams; DM Lasorda; J W Moses; Michael J Cowley; David Eccleston; M C Horrigan; Robert M Bersin; Stephen R Ramee; Ted Feldman
Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).
The American journal of cardiology 2001;87(6):699-705.
2001: M S Chauhan; Richard E Kuntz; K L Ho; David J Cohen; Jeffrey J Popma; Joseph P Carrozza; Donald S Baim; Donald E Cutlip
Coronary artery stenting in the aged.
Journal of the American College of Cardiology 2001;37(3):856-62.
2001: Donald S Baim; Donald E Cutlip; M Midei; TJ Linnemeier; T Schreiber; D Cox; Dean J Kereiakes; Jeffrey J Popma; L Robertson; R Prince; Alexandra J Lansky; Kalon K L Ho; Richard E Kuntz
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries.
The American journal of cardiology 2001;87(2):157-62.
2001: Donald S Baim; Donald E Cutlip; Charles O'Shaughnessy; James Hermiller; Dean J Kereiakes; A Giambartolomei; S Katz; Alexandra J Lansky; M Fitzpatrick; Jeffrey J Popma; Kalon K L Ho; Martin B Leon; Richard E Kuntz
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries.
The American journal of cardiology 2001;87(2):152-6.
2000: Deborah A Taira; Todd B Seto; Kalon K L Ho; Harlan Krumholz; Donald E Cutlip; Ronna H Berezin; Richard E Kuntz; David J Cohen
Impact of smoking on health-related quality of life after percutaneous coronary revascularization.
Circulation 2000;102(12):1369-74.
2000: Todd B Seto; Deborah A Taira; Ronna H Berezin; M S Chauhan; Donald E Cutlip; K K Ho; R E Kuntz; D J Cohen
Percutaneous coronary revascularization in elderly patients: impact on functional status and quality of life.
Annals of internal medicine 2000;132(12):955-8.
2000: Donald S Baim; W D Knopf; Tom Hinohara; D E Schwarten; R A Schatz; C A Pinkerton; Donald E Cutlip; M Fitzpatrick; Kalon K L Ho; Richard E Kuntz
Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials.
The American journal of cardiology 2000;85(7):864-9.
1999: Donald E Cutlip; Martin B Leon; Kalon K L Ho; P C Gordon; A Giambartolomei; DJ Diver; DM Lasorda; David O Williams; M M Fitzpatrick; A Desjardin; Jeffrey J Popma; Richard E Kuntz; Donald S Baim
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry.
Journal of the American College of Cardiology 1999;34(3):698-706.
1999: Alexandra J Lansky; Jeffrey J Popma; Donald E Cutlip; Kalon K L Ho; Andrea S Abizaid; Jorge F Saucedo; Y Zhang; C Senerchia; Richard E Kuntz; Martin B Leon; Donald S Baim
Comparative analysis of early and late angiographic outcomes using two quantitative algorithms in the Balloon versus Optimal Atherectomy Trial (BOAT).
The American journal of cardiology 1999;83(12):1611-6.
1998: Martin B Leon; Donald S Baim; Jeffrey J Popma; P C Gordon; Donald E Cutlip; Kalon K L Ho; A Giambartolomei; DJ Diver; DM Lasorda; David O Williams; S J Pocock; Richard E Kuntz
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
The New England journal of medicine 1998;339(23):1665-71.
1998: Charles A Simonton; Martin B Leon; Donald S Baim; Tom Hinohara; Kenneth M Kent; Robert M Bersin; B Hadley Wilson; Gary S Mintz; Peter J Fitzgerald; Paul G Yock; Jeffrey J Popma; Kalon K L Ho; Donald E Cutlip; C Senerchia; Richard E Kuntz
'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS).
Circulation 1998;97(4):332-9.
1998: Donald S Baim; Donald E Cutlip; S K Sharma; Kalon K L Ho; R Fortuna; T L Schreiber; R L Feldman; J Shani; C Senerchia; Y Zhang; Alexandra J Lansky; Jeffrey J Popma; Richard E Kuntz
Final results of the Balloon vs Optimal Atherectomy Trial (BOAT)
Circulation 1998;97(4):322-31.
1998: Joseph P Carrozza; James Hermiller; TJ Linnemeier; Jeffrey J Popma; P G Yock; Gary S Roubin; LS Dean; Richard E Kuntz; L Robertson; Kalon K L Ho; Donald E Cutlip; Donald S Baim
Quantitative coronary angiographic and intravascular ultrasound assessment of a new nonarticulated stent: report from the Advanced Cardiovascular Systems MultiLink stent pilot study.
Journal of the American College of Cardiology 1998;31(1):50-6.
1996: Harold L Dauerman; Donald E Cutlip; Frank W Sellke
Intracoronary thrombolysis in the treatment of graft closure immediately after CABG.
The Annals of thoracic surgery 1996;62(1):280-3.
1996: Donald S Baim; Donald E Cutlip; Kalon K L Ho; Jeffrey J Popma; C Senerchia; Richard E Kuntz
Acute results of directional coronary atherectomy in the Balloon Versus Optimal Atherectomy Trial (BOAT) pilot phase.
Coronary artery disease 1996;7(4):290-3.